Investigation of Seasonal Influenza Vaccination Status in Chronic Kidney Failure Patients Undergoing Hemodialysis: A Survey Study

Year 2022, Volume: 12 Issue: 1, 104 - 107, 15.01.2022

Esmeray Mutlu Yılmaz , İsmail Özer

https://doi.org/10.16899/jcm.982961

Abstract

Aim: Respiratory tract infections due to influenza virus are more mortal in hemodialysis patients than in the healthy population. These patients should be provided with influenza vaccination every year. In this study; the frequency of influenza vaccination in hemodialysis patients in our region and the factors affecting it were investigated.
Material and method: A total of 239 patients who had undergone hemodialysis for at least one year were asked the prepared questionnaires. The obtained data were analyzed in SPSS 20 program.
Results: The rate of seasonal influenza vaccination of the patients was 87%. Vaccination rates were found to be significantly higher in patients with a duration of hemodialysis longer than five years and those who were vaccinated in the last year (respectively p=0.02, p=0.016). The rate of pneumococcal vaccination in those vaccinated against influenza and the rate of vaccination in the families of these patients were also found to be significantly higher (p<0.01).
Conclusion: In this study, it was found that influenza vaccination rates were high in patients undergoing hemodialysis in our region. The reason for this is that the influenza vaccine is provided free of charge to those with chronic diseases every year by the Ministry of Health in our country.

Keywords

influenza vaccination, chronic kidney diseases, hemodialysis

References

• 1. Allon M, Depner TA, Radeva M, et al: Impact of dialysis dose and membrane on infection-related hospitalization and death: results of the HEMO Study. J Am Soc Nephrol 2003;14(7):1863-70.
• 2. Guo H, Liu J, Collins AJ, Foley RN: Pneumonia in incident dialysis patients--the United States Renal Data System. Nephrol Dial Transplant 2008; 23(2):680-686.
• 3. Sarnak MJ, Jaber BL: Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int 2000; 58(4):1758-1764.
• 4. Mastalerz-Migas A, Gwiazda E, Brydak LB: Effectiveness of influenza vaccine in patients on hemodialysis--a review. Med Sci Monit 2013; 19:1013-1018.
• 5. Control CfD, Prevention: Prevention and control of influenza; recommendations of the Advisory Committee on Immunization Practices (ACIP). Prevention and control of influenza: recommendations of the Advisory 2003; 52:16-24.
• 6. Fiore AE, Uyeki TM, Broder K, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.
• 7. Eickhoff TC: Immunization against Influenza: Rationale and Recommendations. J Infect Dis 1971; 123(4):446-54.
• 8. Nikoskelainen J, Vaananen P, Forsstrom J, Kasanen A: Influenza vaccination in patients with chronic renal failure. Scand J Infect Dis 1982; 14(4):245-51.
• 9. Mutlu H, Coskun F, Sargin M: The incidence and awareness of vaccination among people aged 65 and over applied to a family medicine outpatient clinic. Ankara Med J 2018; 1:1-13.
• 10. Yılmaz T, Şencan İ, Yılmaz TE, et al. The Assessment of Knowledge Levels and Practices of Family Physicians Practicing in Family Health Centers in Ankara with Regard to Well Child Follow-up. Ankara Med J 2018; 18(3):312-21.
• 11. Wang IK, Lin CL, Lin PC, et al. Effectiveness of influenza vaccination in patients with end-stage renal disease receiving hemodialysis: a population-based study. PLoS One 2013; 8(3):e58317.
• 12. McGrath LJ, Kshirsagar AV, Cole SR, et al. Influenza vaccine effectiveness in patients on hemodialysis: an analysis of a natural experiment. Arch Intern Med 2012; 172(7):548-54.
• 13. Wilmore SM, Philip KE, Cambiano V, et al. Influenza and pneumococcal vaccinations in dialysis patients in a London district general hospital. Clin Kidney J 2014; 7(1):27-32.
• 14. Eder M, Omic H, Gorges J, et al. Influenza vaccination uptake and factors influencing vaccination decision among patients with chronic kidney or liver disease. PloS one 2021; 16(4):e0249785.
• 15. Landi F, Onder G, Cesari M, et al. In a prospective observational study, influenza vaccination prevented hospitalization among older home care patients. J Clin Epidemiol 2006; 59(10):1072-77.
• 16. Grohskopf LA, Bresee JS, Cox N, Shimabukuro TT Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)--United States, 2012-13 influenza season. 2012.
• 17. Duggal T, Segal P, Shah M, Carter-Monroe N, Manoharan P, Geetha D Antineutrophil cytoplasmic antibody vasculitis associated with influenza vaccination. Am J Nephrol 2013; 38(2):174-78.
• 18. Cavdar C, Sayan M, Sifil A, et al. The comparison of antibody response to influenza vaccination in continuous ambulatory peritoneal dialysis, hemodialysis and renal transplantation patients. Scand J Urol Nephrol 2003; 37(1):71-76.
• 19. Koşan C. Aşilarin Kronik Diyaliz Hastalarında Kullanımı. MJAU 2002; 34:25-29
• 20. Jordan MC, Rousseau WE, Tegtmeier GE, Noble GR, Muth RG, Chin TD. Immunogenicity of inactivated influenza virus vaccine in chronic renal failure. Ann Intern Med 1973; 79(6):790-794.
• 21. Kunisaki KM, Janoff EN: Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. The Lancet Infectious Diseases 2009, 9(8):493-504.